ST
Strides Pharma Science Limited
STAR.NS · NSE
₹1,082.10 -0.42% (-₹4.60)
1M -7.81%
Market Cap ₹99.8B
P/E Ratio 16.27x
Div. Yield 0.46%
ROE 21.81%
Bulios Fair Price
₹1,094
1.1% upside
Current Price
₹1,082
Undervalued Fair Value Overvalued
According to Bulios Fair Price, STAR.NS is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
62 /100
Fair P/E 16.27x
EV/EBITDA 10.86x
P/S 1.99x
Growth
71 /100
Growing Rev. growth 9.82%
Book val. growth 11.99%
EPS growth N/A
Profitability
59 /100
Moderate Gross margin 36.74%
Net margin 12.26%
Op. margin 14.53%
Quality
77 /100
Excellent ROIC 11.92%
ROE 21.81%
ROA 8.86%
Debt
69 /100
Low Debt/Equity 0.57x
Current ratio 1.25x
Int. coverage 4.96x
Stability
47 /100
Moderate Beta 0.39x
Rev. volatility 6.38%
EPS volatility 226.29%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STAR.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Badree Komandur
Employees
3,535
Headquarters
Bengaluru
Upcoming events
29 OCT
Earnings
Upcoming earnings report